Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Lessons From NASA Help This Fund Find Stocks That Rocket Up

Steven Smith says risk controls he learned as a NASA engineer amid the lunar landing program helped make his portfolio one of the best mutual funds.

Investors Business Daily

Australia approves two new medicines in the fight against COVID. How can you get them and are they effective against Omicron?

On Thursday, health minister Greg Hunt announced Australia’s drug regulator had provisionally approved two new medicines for the treatment of COVID.

The Conversation

Children aged 5-11 OK'd to be vaccinated in Japan

The Health, Labor and Welfare Ministry on Friday gave fast-track approval to the inoculation of children aged 5 to 11 with a coronavirus vaccine from U.S. pharmaceutical firm Pfizer Inc.

The Japan News/Yomiuri

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer jabs for 5-11s to arrive next week

The next batch of 3 million doses of Pfizer Covid-19 vaccine will arrive in the kingdom on Jan 26 to inoculate children aged five to 11 years, Public Health Minister Anutin Charnvirakul said on Thursday.

Bangkok Post

Covid live: Ireland to lift almost all curbs from 6am on Saturday; France reports 400,851 new cases — as it happened

Ireland’s premier Micheál Martin says ‘we have weathered the Omicron storm’; France reports 400,851 daily cases and 233 Covid-linked hospital deaths

The Guardian - UK

This Is What Whales Are Betting On Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 35 strange trades.

Benzinga

Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field

Key Takeaways

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer Trends Sideways, But A Looming Catalyst Could Arrive Next Month

White House advisor Anthony Fauci said U.S. officials could authorize Pfizer and BioNTech's Covid vaccine for children younger than 5 next month.

Investors Business Daily

Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters

According to a small preliminary laboratory study, omicron-neutralizing antibodies in people vaccinated with Russia's

Benzinga

Fauci says children under 5 could be authorised for Pfizer vaccine in weeks

The US has seen record hospitalisations among children below 5 years due to the surge in Omicron cases

The Independent UK

Unilever won't up £50bn offer for GSK-Pfizer unit

LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.

Bangkok Post

France to ease restrictions; Austrian parliament approves mandatory vaccination – as it happened

French PM says from February work from home guidance will be changed and nightclubs reopen; Austria will have Europe’s first universal jabs mandate

The Guardian - UK

Early omicron breakthroughs show mRNA vaccines’ weakness

Booster shots with messenger RNA vaccines such as those made by Pfizer Inc. and BioNTech SE failed to block omicron in a study of some of the first documented breakthrough cases caused by the highly contagious variant.

Tribune News Service

Pfizer CEO awarded $1M Genesis Prize for developing COVID vaccine

Albert Bourla is recognised for being at the forefront of fighting the pandemic and developing a vaccine in record time.

Al Jazeera

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Pfizer's COVID-19 Oral Antiviral Shows In-Vitro Efficacy Against Omicron Variant

Pfizer Inc (NYSE: PFE) yesterday

The New Daily

Booster shots offer ‘much better protection’ against symptomatic COVID-19

There is good evidence that booster shots offer much greater protection against symptomatic disease, serious disease and death.

The Independent UK

Pfizer chief Albert Bourla wins $1 million Genesis Prize

Pfizer's chief executive, Albert Bourla, has been awarded the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine

Salon

Four doses not enough to stop omicron

Omicron's vaccine-resistant properties have prompted Pfizer to start work on an omicron-specific vaccine

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Should I mix or match my booster? Your COVID-19 vaccine questions answered

For many Australians, it’s now time for a COVID booster – but which one should you be getting? Read our handy guide to find out.

Investors Business Daily

This New Study Suggests Pfizer, BioNTech Are Losing The Omicron Battle

A fourth dose of Pfizer and BioNTech's Covid shot is only partly effective against omicron, according to a new test. The vaccine stocks fell.

Benzinga

Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal

Novasep

Benzinga

FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis

Along with AbbVie Inc's (NYSE: ABBV)

Benzinga

Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed

Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults.

Asharq Al-Awsat

Macron Touts Rosy French Economy, New Jobs Ahead of Election

President Emmanuel Macron on Monday touted 21 new foreign investment projects in France and a booming economy as proof his economic reforms have been bearing fruit less than three months before a presidential election in which he is expected to run. During a visit to Alsace in the east, Macron…

Newcastle Herald

Why getting boosted is a pain in the arm

Have you had "Pfizer boob" after COVID booster?

1 … 72 73 74 75

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.